Clear Gene

Clear Gene is a biotechnology startup that focuses on RNA diagnostics. Its slogan, "Improving diagnostics, from cancer to Covid," reflects its dedication to enhancing diagnostic processes. Founded in 2012, the company initially concentrated on using data science and molecular assays to advance cancer tests. However, it pivoted during the pandemic, swiftly developing a rapid COVID-19 test for clinical labs. This innovative response was supported by the repurposing of Clear Gene's cloud-based software to aid labs in analyzing results from their existing PCR instruments without local software installation delays. The recent Seed Round investment received on 01 December 2021 was backed by Unpopular Ventures and Founders, Inc. Clear Gene's ability to effectively adapt to urgent global needs while maintaining a commitment to methodical product development underscores its potential in the biotechnology industry, where innovation is paramount.